Varex Imaging Corporation (VREX)
- Previous Close
15.89 - Open
15.83 - Bid 15.31 x 100
- Ask 15.41 x 100
- Day's Range
14.93 - 15.83 - 52 Week Range
14.56 - 23.90 - Volume
468,485 - Avg. Volume
341,403 - Market Cap (intraday)
627.548M - Beta (5Y Monthly) 0.72
- PE Ratio (TTM)
16.70 - EPS (TTM)
0.92 - Earnings Date Jul 30, 2024 - Aug 5, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
25.00
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. The company sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was incorporated in 2016 and is headquartered in Salt Lake City, Utah.
www.vareximaging.comRecent News: VREX
Performance Overview: VREX
Trailing total returns as of 5/10/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: VREX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: VREX
Valuation Measures
Market Cap
627.55M
Enterprise Value
909.25M
Trailing P/E
16.70
Forward P/E
42.73
PEG Ratio (5yr expected)
6.10
Price/Sales (ttm)
0.91
Price/Book (mrq)
1.09
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
4.90%
Return on Assets (ttm)
3.09%
Return on Equity (ttm)
7.55%
Revenue (ttm)
855.8M
Net Income Avi to Common (ttm)
41.9M
Diluted EPS (ttm)
0.92
Balance Sheet and Cash Flow
Total Cash (mrq)
188.9M
Total Debt/Equity (mrq)
79.87%
Levered Free Cash Flow (ttm)
93.89M
Research Analysis: VREX
Company Insights: VREX
VREX does not have Company Insights